Skip to main content

MoneyWorks4Me

Ambalal Sarabhai Enterprises informs about compliances-certificate

20 Oct 2022 Evaluate
Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, Ambalal Sarabhai Enterprises has informed that it enclosed a confirmation certificate received from MCS Share Transfer Agent, the Registrar and Transfer Agent of the Company for the period ended on 30th September, 2022. 

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1825.35
Dr. Reddys Labs. 1360.80
Cipla 1401.75
Lupin 1987.50
Zydus Lifesciences 1196.40
View more..